FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, specifically to obtaining modified peptide epitopes, and can be used in medicine for treating obesity. Disclosed is a peptide which can be recognized by a CD4+ T-cell for inducing a humoral immune response, wherein the peptide consists of RNVPPIFNDVYWIAFZaK(Cha)VAAWTLKAACR, where a denotes the D-form of alanine, (Cha) denotes L-cyclohexylalanine and Z denotes 6-aminohexanoic acid. Also disclosed is a composition for treating obesity containing said peptide.
EFFECT: invention enables to obtain a peptide effective in reducing body weight and fat deposits.
3 cl, 25 dwg, 15 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIGENIC PEPTIDES FOR PREVENTION AND TREATMENT OF B-CELL HEMOBLASTOSIS | 2020 |
|
RU2833806C1 |
| CHIMERIC CYTOKINE RECEPTORS CARRYING PD-1 ECTODOMAIN | 2020 |
|
RU2828214C2 |
| N-GALLATES OF SYNTHETIC PEPTIDES WITH ANTIOXIDANT ACTIVITY | 2023 |
|
RU2828796C1 |
| BISPECIFIC ANTIBODIES AND THEIR APPLICATIONS | 2022 |
|
RU2821577C2 |
| PROPERDIN ANTIBODIES AND PRODUCTION THEREOF | 2021 |
|
RU2830308C1 |
| PEPTIDES HAVING ANTIBACTERIAL ACTIVITY | 2024 |
|
RU2837372C1 |
| NUCLEOTIDE SEQUENCE CODING LYTICASE ENZYME, AND PANEL OF OLIGONUCLEOTIDES FOR OBTAINING SYNTHETIC NUCLEOTIDE SEQUENCE OF LYTICASE GENE | 2023 |
|
RU2826150C1 |
| MICROORGANISM OF GENUS CORYNEBACTERIUM, PRODUCING L-ARGININE, AND METHOD OF PRODUCING L-ARGININE USING SAID MICROORGANISM | 2022 |
|
RU2837670C2 |
| METHOD FOR GENOTYPING NEISSERIA GONORRHOEAE ISOLATES ON BIOLOGICAL MICROCHIP | 2023 |
|
RU2816767C1 |
| METHOD OF PRODUCING MOUSE MODEL FOR STUDYING DUCHENNE MUSCULAR DYSTROPHY AND VERSIONS OF ITS THERAPY | 2023 |
|
RU2815936C1 |
